No Increased Risk of Posttransplant Lymphoproliferative Disorder Following Alemtuzumab Induction in Kidney Transplant

Posttransplant lymphoproliferative disorder is a known complication of solid-organ transplant. The use of depleting induction agents has demonstrated varying associations with incidence of posttransplant lymphoproliferative disorder. Alemtuzumab, a depleting induction agent for kidney transplant pat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Experimental and clinical transplantation 2019-06, Vol.17 (3), p.320-325
Hauptverfasser:	Oliver, Madeleine, Mitro, Graham, Tenbrink, Patrick, Alharthi, Samer, Bedford, Nastassja, Wu, Jinling, Gohara, Amira, Jordan, Matthew, Zaremba, Cassandra, Rees, Michael, Ortiz, Jorge
Format:	Artikel
Sprache:	eng
Schlagworte:	Tıp
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!